Oxygen News and Research

RSS

Review: Endovascular therapy is the safest, most effective treatment for superior vena cava syndrome

Like a blocked water line, obstructions in blood vessels in the human circulatory system can cause serious problems.

28 Jun 2021

Could microalgae-derived antiviral compounds combat SARS-CoV-2 and other viruses?

A new review article published in the journal Antibiotics reports the presence of a large number of bioactive compounds in microalgae that target chemical structures present only in their structure.

28 Jun 2021

Tocilizumab and sarilumab shown to be effective in critical COVID-19

A new study, released as a preprint on the medRxiv* server, describes how a team of researchers from the University Medical Center Utrecht in the Netherlands explored the efficacy of four monoclonal antibodies that antagonize powerful pro-inflammatory pathways. The team sought to determine which were useful in treating critically ill COVID-19 patients on organ support.

28 Jun 2021

Differences in human and mouse brain cells have implications for research into neurological disorders

A UCLA-led study comparing brain cells known as astrocytes in humans and mice found that mouse astrocytes are more resilient to oxidative stress, a damaging imbalance that is a mechanism behind many neurological disorders.

25 Jun 2021

Fundamental insights on key protein can help strengthen plants against environmental stress

An international study led by Helmholtz Zentrum München has revealed the structure of a membrane-remodeling protein that builds and maintains photosynthetic membranes. These fundamental insights lay the groundwork for bioengineering efforts to strengthen plants against environmental stress, helping to sustaining human food supply and fight against climate change.

25 Jun 2021

Is COVID-19 more severe in pregnancy?

A new study, released as a preprint on the medRxiv* server, indicates that pregnant women are more likely to develop severe disease following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

24 Jun 2021

SARS-CoV-2 causes ER-stress-activated unfolded protein response leading to cell death

A new study describes the varying ways in which the virus co-opts the machinery of the host cell following infection to evade or modulate the host immune response, alter the pattern of translation of viral proteins, and the release of new viral particles.

24 Jun 2021

Researchers uncover new function of regulator protein in multiple myeloma development

A specific regulatory protein significantly influences the development of tumor-inducing blood vessels in the bone marrow of blood cancer patients.

24 Jun 2021

Researchers reanalyze COVID RECOVERY trial data on tocilizumab

A Bayesian analysis of the RECOVERY trial suggests the immunosuppressive drug tocilizumab can reduce deaths in hospitalized COVID-19 patients taking corticosteroids as well as patients on oxygen or non-invasive ventilation and likely increases hospital discharge rates. However, it is not clear if patients on invasive ventilation also benefit.

24 Jun 2021

Study finds no evidence for remdesivir's benefit in severe COVID-19 patients

A new analysis of current data indicates that remdesivir does not show efficacy in regulating the severity of the illness.

23 Jun 2021

CD39+ monocyte count higher in pregnant than non-pregnant COVID-19 patients

A new study published on the bioRxiv* server describes the changes in the representation of a subset of activated monocytes in this group of patients.

23 Jun 2021

Increasing novel lncRNA in cardiomyocytes can inhibit the progression of heart failure

A research collaboration based in Kumamoto University (Japan) has identified a novel lncRNA, Caren, that is abundantly expressed in cardiomyocytes.

23 Jun 2021

Can antioxidants help manage neurological complications in COVID-19?

In a recent study published in Antioxidants, researchers evaluated the use of antioxidants as potential adjuvants for the treatment of COVID-19.

23 Jun 2021

Repurposing immunomodulatory drugs to treat COVID-19

EULAR has released new points to consider on the use of immunomodulatory drugs in the fight against severe COVID-19.

23 Jun 2021

University Hospitals in Northeast Ohio performs first innovative heart procedure

A University Hospitals (UH) patient is the first in Northeast Ohio to undergo a new, innovative procedure called CCM® therapy. UH is among the first hospitals in the United States and the only hospital in Northeast Ohio to use CCM therapy, delivered by the Optimizer® system, to treat patients suffering from heart failure.

23 Jun 2021

Mother's gestational diabetes is an independent risk factor for fetal hypoxia during labor

In Finland, every fifth mother was diagnosed with gestational diabetes in 2019. The condition increases the mother's risk of developing type 2 diabetes in the future.

22 Jun 2021

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib (Yeliva®, ABC294640) in hospitalized patients with COVID-19 pneumonia at the World Microbe Forum (WMF) 2021 (poster #: 5574).

21 Jun 2021

Oxygen News and Research

Review: Endovascular therapy is the safest, most effective treatment for superior vena cava syndrome

Could microalgae-derived antiviral compounds combat SARS-CoV-2 and other viruses?

Tocilizumab and sarilumab shown to be effective in critical COVID-19

Differences in human and mouse brain cells have implications for research into neurological disorders

Fundamental insights on key protein can help strengthen plants against environmental stress

Is COVID-19 more severe in pregnancy?

SARS-CoV-2 causes ER-stress-activated unfolded protein response leading to cell death

Researchers uncover new function of regulator protein in multiple myeloma development

Researchers reanalyze COVID RECOVERY trial data on tocilizumab

Study finds no evidence for remdesivir's benefit in severe COVID-19 patients

CD39+ monocyte count higher in pregnant than non-pregnant COVID-19 patients

Increasing novel lncRNA in cardiomyocytes can inhibit the progression of heart failure

Can antioxidants help manage neurological complications in COVID-19?

Repurposing immunomodulatory drugs to treat COVID-19

University Hospitals in Northeast Ohio performs first innovative heart procedure

Mother's gestational diabetes is an independent risk factor for fetal hypoxia during labor

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

Discovery provides new target to make melanomas more vulnerable to anti-cancer treatments

COVID-19 studies should provide sex-disaggregated data, researchers warn

Baseline use of DMARDs linked with COVID-19 severity in rheumatoid arthritis patients

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC